1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
- Read more in our News Archive
Current Studies at Motherisk
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Environmental Exposures and Children's Health
Alcohol Use during Pregnancy
Control of Hypertension in Pregnancy Study
Folic Acid Before and During Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Motherisk Nausea and Vomiting of Pregnancy (NVP) ForumMotherisk receives questions from around the world about morning sickness symptoms, effects, treatments and ways to cope. Those questions and answers are posted here for anyone to read, provided the reader acknowledges and accepts the proviso and disclaimer below.
what is your opinion about taking Kytril for NVP. what does the research show and a general recommendation.
There is no information on Kytril in pregnancy. However, it is in the same group of drugs as ondansetron (Zofran). The Motherisk study on Zofran was published in the September issue of the British Journal of Obstetrics and Gynecology. Out of 176 women on Zofran who were followed up after they gave birth, 6 had babies with birth defects (3 of which were hypospadias - a very common defect present in 1 out of 300 male babies). This falls within the 1 to 3 percent baseline risk for malformation that is present in any pregnancy.
Please view our treatment algorithm for more information, consult your physician, and/or speak to a teratogen information counselor. If you are in the US, visit the OTIS website for a teratogen information service in your area.